Updated November 7, 2022
Saturday, May 30, 2009
Men - Study Says Drink Wine and Live Longer
Wednesday, May 27, 2009
Drugs - Devices - Preemption - Explained Clearly
My hat is off to Matt Hotz, on the Pharma Compliance Blog, for writing this succinct and consumable post that even I can understand, Preemption and the Distinction between Drugs and Devices. I'm not a lawyer, so I've found this particular topic difficult to digest. Hotz' post got me up to speed quickly and expanded my understanding of the touchpoints to local, state, vs. federal law; and to the distinctions and nuances between drugs vs. medical devices. Now I feel that I can follow breaking preemption news with some basic foundational understanding. Thanks Matt!
Monday, May 25, 2009
FDA Guidance - FDA and Sponsor-Applicant Meetings
Saturday, May 23, 2009
See Clearly - It Is Healthy Vision Month
Wednesday, May 20, 2009
FDA Updates MAPP On Human Research
This MAPP is a revision of an earlier MAPP originally numbered 4112.6. The MAPP’s change in number reflects the establishment of the Office of Translational Sciences (OTS) within CDER.
Additional FDA Resources:
- 45 CFR part 46 http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm
- "Ethical Principles and Guidelines for the Protection of Human Subjects of Research," the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, Office of the Secretary, HHS, April 18, 1979 (the Belmont Report) http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm
- "Federal-wide Assurance of Protection for Human Subjects," OHRP, HHS http://www.hhs.gov/ohrp/assurances/assurances_index.html
- Protecting Personal Health Information in Research: Understanding the HIPAA Privacy Rule (http://privacyruleandresearch.nih.gov/pr_02.asp)
- Information Sheet Guidances - Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
Monday, May 18, 2009
Cheerios Aside . . . FDA Gives Guidance On OTC Labels (pdf)
- FDA GMP QSR cGMP Online Training: FDA cGMP QSR GMP Online Training - popular online training courses by SkillsPlus International Inc. #FDA #cGMP #GMP #QSR #training
The link broke in the original post.
You might also be interested in:
FDA Guidance for Industry - Labeling OTC Human Drug Products — Questions and
Answers (PDF) found on this FDA webpage Labeling OTC Human Drug Products -- Questions and Answers
- - - original post follows below - - -
OK, now that we can chuckle about the Cheerios label fiasco, here's the scoop on what should go on OTC labels, "FDA Guidance for Industry - Labeling OTC Human Drug Products (PDF)"
In a nutshell, the Food and Drug Administration (FDA) has prepared this guidance in accordance with section 212 of the Small Business Regulatory Enforcement Fairness Act. It is intended to help small businesses better understand the new over-the-counter (OTC) labeling requirements set forth in 21 CFR 201.66 and prepare new labeling.
If you're new to this arena, you'll find this a real eye opener. The FDA even regulates things down to the detail of what size font you need to use, and more!
Return Home: http://drughealth.blogspot.com/
Saturday, May 16, 2009
FDA Says Cheerios Makes False Claims
The FDA tells General Mills CEO, "The Food and Drug Administration (FDA) has reviewed the label and labeling of your Cheerios® Toasted Whole Grain Oat Cereal. FDA's review found serious violations of the Federal Food, Drug, and Cosmetic Act (the Act) and the applicable regulations in Title 21, Code of Federal Regulations (21 CFR). You can find copies of the Act and these regulations through links in FDA's home page at http://www.fda.gov." Ooooh, what a spanking! ... as reported in this FDA Warning Letter to Ken Powell, Chairman of the Board and CEO. Read more about this on this Fox Austin article, "FDA: Cheerios Makes False Health Claims.
Friday, May 15, 2009
FDA - Transdermal Patches - MRI Burning Risk (Podcast)
A quick re-reminder that not all transdermal patches come with labelling warning patients about the burning risk while undergoing an MRI exam. Listen to this FDA Podcast, Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings, or read the transcript "Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings."
Wednesday, May 13, 2009
FDA Expected To Rule On Mercury Dental Amalgams
Monday, May 11, 2009
FDA Publishes Rulemaking Histories For OTC Drugs
If you're in the Over-The-Counter (OTC), non-prescription drug business, then this FDA collection might be of some interest to you: Rulemaking History for Nonprescription Products: Drug Category List. The Over-the-Counter (OTC) drug category collection contains Federal Register notices organized by therapeutic category subtopics. Each child collection links to therapeutic category pages organized chronologically. Pretty nice. For example, you can scan the Federal Register history for something like, Hair Growth and Loss, Male Genital Desensitizers, or Weight Control.
Saturday, May 9, 2009
University Researcher Compares Carbon Nanotubes to Asbestos (video)
I found this YouTube video that helps me visualize how asbestos is physically similar to carbon nanotubes (CNT), Are Carbon Nanotubes the Next Asbestos? (video): Under a microscope, CNTs look identical to asbestos fibers, leading scientists to believe that they could cause similar health problems. In this video, North Carolina State University (NCSU) researcher, Dr. Jamie Bonner, shares his research on the potential toxicity of carbon nanotubes.
Friday, May 8, 2009
CDC Says Mesothelioma Deaths Increasing
Morbidity and Mortality Weekly Report (MMWR) reports mesothelioma fatalities over the past several years, Malignant Mesothelioma Mortality --- United States, 1999--2005. In a nutshell . . . CDC's National Institute for Occupational Safety and Health (NIOSH) analyzed annual multiple-cause-of-death records for 1999--2005, the most recent years for which complete data are available. For those years, a total of 18,068 deaths of persons with malignant mesothelioma were reported, increasing from 2,482 deaths in 1999 to 2,704 in 2005. The agency expects the number of mesothelioma deaths to peak next year, and to begin to decline, as the improvements in safety and reduction in asbestos use instituted decades ago payoff. The latency period of mesothelioma can be decades long, so even though asbestos is used less widely today, people continue to get mesothelioma due to their exposure in the past. What's concerning is, "Recent studies suggest that carbon nanotubes (fiber-shaped nanoparticles), which are increasingly being used in manufacturing (9), might share the carcinogenic mechanism postulated for asbestos and induce mesothelioma (10), underscoring the need for documentation of occupational history in future cases. Capturing occupational history information for mesothelioma cases is important to identify industries and occupations placing workers at risk for this lethal disease."
Wednesday, May 6, 2009
Swine Flu - Be Happy - - - FDA Worries About Mad Cow Disease - BSE
The world is a dangerous place. Where can you go to escape the scourge of swine flu?! OK, a little melodramatic. In any event, the U.S. Food and Drug Administration (FDA) released a final guidance document April 30 about the substances prohibited for use in animal feed, relating to its new rule to protect against bovine spongiform encephalopathy (BSE). The so-called BSE rule became effective April 27, but renderers will have additional time to comply with new requirements. The FDA's established compliance date is Oct. 26. The new guidance document should help slaughter facilities and farms supplying offal and dead livestock to renderers to understand their responsibilities in regard to the new rule. Feeling any safer?! FDA Reference Documents: FDA Issues Final Guidance for Renderers on Substances Prohibited From Use in Animal Food or Feed GUIDANCE FOR INDUSTRY SMALL ENTITIES COMPLIANCE GUIDE FOR RENDERERS—SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED (pdf) FDA Page on Bovine Spongiform Encephalopathy (BSE)
Monday, May 4, 2009
Medical Devices Infected By The Conficker PC Worm
Be very afraid. Hospital and medical devices have been found to be infected by a computer worm (kind of like a virus), reports this Mercury News article, Conficker worm hits hospital devices, "A computer worm that has alarmed security experts around the world has crawled into hundreds of medical devices at dozens of hospitals in the United States and other countries, according to technologists monitoring the threat." What I find so disturbing in the article is, "the working group has seen thousands of other machines located in hospitals reach out to the Conficker mastermind by contacting another computer on the Internet for instructions." The potential danger could be leaking of your health information, or the medical devices could be recruited as robots in an attack on other computer systems. Isn't technology grand!?